{"id":45190,"date":"2022-06-16T23:02:02","date_gmt":"2022-06-16T21:02:02","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/novanta-to-present-at-the-cjs-securities-22nd-annual-new-ideas-summer-conference-on-tuesday-july-12-2022\/"},"modified":"2022-06-16T23:02:02","modified_gmt":"2022-06-16T21:02:02","slug":"novanta-to-present-at-the-cjs-securities-22nd-annual-new-ideas-summer-conference-on-tuesday-july-12-2022","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/novanta-to-present-at-the-cjs-securities-22nd-annual-new-ideas-summer-conference-on-tuesday-july-12-2022\/","title":{"rendered":"Novanta to Present at the CJS Securities 22nd Annual \u201cNew Ideas\u201d Summer Conference on Tuesday, July 12, 2022"},"content":{"rendered":"
\n

BEDFORD, Mass.–(BUSINESS WIRE)–Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matthijs Glastra, Chair & Chief Executive Officer, and Robert Buckley, Chief Financial Officer, are scheduled to present at the CJS Securities 22nd<\/sup> Annual \u201cNew Ideas\u201d Summer Conference on Tuesday, July 12, 2022, which is being held in Greenwich, CT.\n<\/p>\n

<\/a><\/p>\n

\nAbout Novanta<\/b>\n<\/p>\n

\nNovanta is a leading global supplier of core technology solutions that give medical and advanced industrial original equipment manufacturers (\u201cOEMs\u201d) a competitive advantage. We combine deep proprietary technology expertise and competencies in photonics, vision and precision motion with a proven ability to solve complex technical challenges. This enables Novanta to engineer core components and sub-systems that deliver extreme precision and performance, tailored to our customers\u2019 demanding applications. The driving force behind our growth is the team of innovative professionals who share a commitment to innovation and customer success. Novanta\u2019s common shares are quoted on Nasdaq under the ticker symbol \u201cNOVT\u201d.\n<\/p>\n

\nMore information about Novanta is available on the Company\u2019s website at www.novanta.com<\/a>. For additional information, please contact Novanta Inc. Investor Relations at (781) 266-5137 or InvestorRelations@novanta.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nNovanta Inc.<\/b>
Investor Relations Contact:
\n
Ray Nash
\n
(781) 266-5137\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

BEDFORD, Mass.–(BUSINESS WIRE)–Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matthijs Glastra, Chair & Chief Executive Officer, and Robert Buckley, Chief Financial Officer, are scheduled to present at the CJS Securities 22nd Annual \u201cNew Ideas\u201d Summer Conference on Tuesday, July 12, 2022, which … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-45190","6":"format-standard","7":"category-industry"},"yoast_head":"\nNovanta to Present at the CJS Securities 22nd Annual \u201cNew Ideas\u201d Summer Conference on Tuesday, July 12, 2022 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/novanta-to-present-at-the-cjs-securities-22nd-annual-new-ideas-summer-conference-on-tuesday-july-12-2022\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Novanta to Present at the CJS Securities 22nd Annual \u201cNew Ideas\u201d Summer Conference on Tuesday, July 12, 2022 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"BEDFORD, Mass.–(BUSINESS WIRE)–Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matthijs Glastra, Chair & Chief Executive Officer, and Robert Buckley, Chief Financial Officer, are scheduled to present at the CJS Securities 22nd Annual \u201cNew Ideas\u201d Summer Conference on Tuesday, July 12, 2022, which ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/novanta-to-present-at-the-cjs-securities-22nd-annual-new-ideas-summer-conference-on-tuesday-july-12-2022\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-06-16T21:02:02+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220616005051\/en\/686477\/21\/novanta_logo_rgb.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/novanta-to-present-at-the-cjs-securities-22nd-annual-new-ideas-summer-conference-on-tuesday-july-12-2022\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/novanta-to-present-at-the-cjs-securities-22nd-annual-new-ideas-summer-conference-on-tuesday-july-12-2022\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Novanta to Present at the CJS Securities 22nd Annual \u201cNew Ideas\u201d Summer Conference on Tuesday, July 12, 2022\",\"datePublished\":\"2022-06-16T21:02:02+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/novanta-to-present-at-the-cjs-securities-22nd-annual-new-ideas-summer-conference-on-tuesday-july-12-2022\\\/\"},\"wordCount\":220,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/novanta-to-present-at-the-cjs-securities-22nd-annual-new-ideas-summer-conference-on-tuesday-july-12-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220616005051\\\/en\\\/686477\\\/21\\\/novanta_logo_rgb.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/novanta-to-present-at-the-cjs-securities-22nd-annual-new-ideas-summer-conference-on-tuesday-july-12-2022\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/novanta-to-present-at-the-cjs-securities-22nd-annual-new-ideas-summer-conference-on-tuesday-july-12-2022\\\/\",\"name\":\"Novanta to Present at the CJS Securities 22nd Annual \u201cNew Ideas\u201d Summer Conference on Tuesday, July 12, 2022 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/novanta-to-present-at-the-cjs-securities-22nd-annual-new-ideas-summer-conference-on-tuesday-july-12-2022\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/novanta-to-present-at-the-cjs-securities-22nd-annual-new-ideas-summer-conference-on-tuesday-july-12-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220616005051\\\/en\\\/686477\\\/21\\\/novanta_logo_rgb.jpg\",\"datePublished\":\"2022-06-16T21:02:02+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/novanta-to-present-at-the-cjs-securities-22nd-annual-new-ideas-summer-conference-on-tuesday-july-12-2022\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/novanta-to-present-at-the-cjs-securities-22nd-annual-new-ideas-summer-conference-on-tuesday-july-12-2022\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/novanta-to-present-at-the-cjs-securities-22nd-annual-new-ideas-summer-conference-on-tuesday-july-12-2022\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220616005051\\\/en\\\/686477\\\/21\\\/novanta_logo_rgb.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220616005051\\\/en\\\/686477\\\/21\\\/novanta_logo_rgb.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/novanta-to-present-at-the-cjs-securities-22nd-annual-new-ideas-summer-conference-on-tuesday-july-12-2022\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Novanta to Present at the CJS Securities 22nd Annual \u201cNew Ideas\u201d Summer Conference on Tuesday, July 12, 2022\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Novanta to Present at the CJS Securities 22nd Annual \u201cNew Ideas\u201d Summer Conference on Tuesday, July 12, 2022 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/novanta-to-present-at-the-cjs-securities-22nd-annual-new-ideas-summer-conference-on-tuesday-july-12-2022\/","og_locale":"en_US","og_type":"article","og_title":"Novanta to Present at the CJS Securities 22nd Annual \u201cNew Ideas\u201d Summer Conference on Tuesday, July 12, 2022 - Pharma Trend","og_description":"BEDFORD, Mass.–(BUSINESS WIRE)–Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matthijs Glastra, Chair & Chief Executive Officer, and Robert Buckley, Chief Financial Officer, are scheduled to present at the CJS Securities 22nd Annual \u201cNew Ideas\u201d Summer Conference on Tuesday, July 12, 2022, which ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/novanta-to-present-at-the-cjs-securities-22nd-annual-new-ideas-summer-conference-on-tuesday-july-12-2022\/","og_site_name":"Pharma Trend","article_published_time":"2022-06-16T21:02:02+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220616005051\/en\/686477\/21\/novanta_logo_rgb.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/novanta-to-present-at-the-cjs-securities-22nd-annual-new-ideas-summer-conference-on-tuesday-july-12-2022\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/novanta-to-present-at-the-cjs-securities-22nd-annual-new-ideas-summer-conference-on-tuesday-july-12-2022\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Novanta to Present at the CJS Securities 22nd Annual \u201cNew Ideas\u201d Summer Conference on Tuesday, July 12, 2022","datePublished":"2022-06-16T21:02:02+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/novanta-to-present-at-the-cjs-securities-22nd-annual-new-ideas-summer-conference-on-tuesday-july-12-2022\/"},"wordCount":220,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/novanta-to-present-at-the-cjs-securities-22nd-annual-new-ideas-summer-conference-on-tuesday-july-12-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220616005051\/en\/686477\/21\/novanta_logo_rgb.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/novanta-to-present-at-the-cjs-securities-22nd-annual-new-ideas-summer-conference-on-tuesday-july-12-2022\/","url":"https:\/\/pharma-trend.com\/en\/novanta-to-present-at-the-cjs-securities-22nd-annual-new-ideas-summer-conference-on-tuesday-july-12-2022\/","name":"Novanta to Present at the CJS Securities 22nd Annual \u201cNew Ideas\u201d Summer Conference on Tuesday, July 12, 2022 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/novanta-to-present-at-the-cjs-securities-22nd-annual-new-ideas-summer-conference-on-tuesday-july-12-2022\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/novanta-to-present-at-the-cjs-securities-22nd-annual-new-ideas-summer-conference-on-tuesday-july-12-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220616005051\/en\/686477\/21\/novanta_logo_rgb.jpg","datePublished":"2022-06-16T21:02:02+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/novanta-to-present-at-the-cjs-securities-22nd-annual-new-ideas-summer-conference-on-tuesday-july-12-2022\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/novanta-to-present-at-the-cjs-securities-22nd-annual-new-ideas-summer-conference-on-tuesday-july-12-2022\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/novanta-to-present-at-the-cjs-securities-22nd-annual-new-ideas-summer-conference-on-tuesday-july-12-2022\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220616005051\/en\/686477\/21\/novanta_logo_rgb.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220616005051\/en\/686477\/21\/novanta_logo_rgb.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/novanta-to-present-at-the-cjs-securities-22nd-annual-new-ideas-summer-conference-on-tuesday-july-12-2022\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Novanta to Present at the CJS Securities 22nd Annual \u201cNew Ideas\u201d Summer Conference on Tuesday, July 12, 2022"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45190","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=45190"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45190\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=45190"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=45190"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=45190"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}